C-reactive protein (CRP) [2], [3], B-type natriuretic peptide (BNP) [4] and cardiac troponin I (cTnI) [5], [6] can respectively serve as important markers of plaque stability, HF, and myocardial injury, but also collectively serve as prognostic indicators of outcome after AMI. This evidence concerns the gene TNNI3 and hydrops fetalis.